Literature DB >> 6092462

Accessory cell requirement for activation antigen expression and cell cycle progression by human T lymphocytes.

J M Williams, B J Ransil, H M Shapiro, T B Strom.   

Abstract

Stringent accessory cell (AC) depletion by a three-step procedure--plastic adherence, nylon wool adherence, followed by simultaneous treatment with two anti-AC monoclonal antibodies + complement--has allowed the demonstration of several AC-dependent stages in the T cell activation pathway. Simultaneous analysis of DNA content and cell surface immunofluorescence (correlation of activation antigen expression with cell cycle position) or DNA and RNA content (cell cycle position) of cultured cells was accomplished by dual parameter flow cytometry. AC-depleted, PHA-stimulated human peripheral blood T lymphocytes (PBTL) failed to exhibit "early" indicators of activation, including increased RNA content, expression of three activation-associated cell surface proteins (IL 2 receptor, transferrin receptor, and 4F2 protein), and the production of IL 2. The AC-depleted PBTL that failed to express these "early" markers of activation also failed to progress into the "late" phase of activation, DNA synthesis. All indicators of PHA responsiveness were fully replenished upon addition of AC but were only reconstituted to intermediate levels by addition of excess quantities of either highly purified IL 1 or crude AC-conditioned medium with lymphocyte-activating factor activity. These data suggest that the AC membrane plays a key and as yet undefined role in the stimulation of T cells by PHA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6092462

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Expression of cell-cycle-dependent genes in phytohemagglutinin-stimulated human lymphocytes.

Authors:  L Kaczmarek; B Calabretta; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

Review 2.  Regulation of T cell activation by leukotriene B4.

Authors:  J S Goodwin
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

3.  Single strand DNA breaks in mitogen stimulated T lymphocytes are religated by a mechanism independent of accessory cells.

Authors:  D J Harrison; A M Crowe; A H Wyllie
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Development of a chemically defined serum- and protein-free medium for growth of human peripheral lymphocytes.

Authors:  W Shive; F Pinkerton; J Humphreys; M M Johnson; W G Hamilton; K S Matthews
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

5.  Activation of lymphocytes isolated from the gastric mucosa of the mouse.

Authors:  H J Andress; L Brent
Journal:  Immunology       Date:  1987-12       Impact factor: 7.397

6.  Gamma-interferon production by human low-density lymphocytes induced by T-cell mitogens.

Authors:  A D Croll; M F Wilkinson; A G Morris
Journal:  Immunology       Date:  1986-08       Impact factor: 7.397

7.  Reduced human lymphocyte blastogenesis and enhancement of adenosine triphosphate (ATP) by L-carnitine.

Authors:  P Conti; M Reale; S Stuard; G Spoto; F Picerno; T Ferrara; F C Placido; R C Barbacane; A Albertazzi; B M Errichi
Journal:  Mol Cell Biochem       Date:  1994-02-09       Impact factor: 3.396

8.  Macrophages are required for influenza virus infection of human lymphocytes.

Authors:  D J Mock; F Domurat; N J Roberts; E E Walsh; M R Licht; P Keng
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

9.  Endotoxin-associated protein: interleukin-1-like activity on serum amyloid A synthesis and T-lymphocyte activation.

Authors:  M A Johns; J D Sipe; L B Melton; T B Strom; W R McCabe
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

10.  Functional characterization of an antigen involved in an early step of T-cell activation.

Authors:  M E Cosulich; A Rubartelli; A Risso; F Cozzolino; A Bargellesi
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.